Cited by 483Pancreatic function and diabetesDiabetes and associated disordersDiabetes Treatment and Management

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Open access

Ward, W K, Bolgiano, D C, McKnight, B, Halter, J B, Porte, D·1984·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

In order to assess whether patients with noninsulin-dependent diabetes mellitus (NIDDM) possess normal insulin secretory capacity, maximal B cell responsiveness to the potentiating effects of glucose was estimated in eight untreated patients with NIDDM and in eight nondiabetic controls. The acute insulin response to 5 g intravenous arginine was measured at five matched plasma glucose levels that ranged from approximately 100-615 mg/dl. The upper asymptote approached by acute insulin responses (AIRmax) and the plasma glucose concentration at half-maximal responsiveness (PG50) were estimated using nonlinear regression to fit a modification of the Michaelis-Menten equation. In addition, glucagon responses to arginine were measured at these same glucose levels to compare maximal A cell suppression by hyperglycemia in diabetics and controls. Insulin responses to arginine were lower in diabetics than in controls at all matched glucose levels (P less than 0.001 at all levels). In addition, estimated AIRmax was much lower in diabetics than in controls (83 +/- 21 vs. 450 +/- 93 microU/ml, P less than 0.01). In contrast, PG50 was similar in diabetics and controls (234 +/- 28 vs. 197 +/- 20 mg/dl, P equals NS) and insulin responses in both groups approached or attained maxima at a glucose level of approximately 460 mg/dl. Acute glucagon responses to arginine in patients with NIDDM were significantly higher than responses in controls at all glucose levels. In addition, although glucagon responses in control subjects reached a minimum at a glucose level of approximately 460 mg/dl, responses in diabetics declined continuously throughout the glucose range and did not reach a minimum. Thus, A cell sensitivity to changes in glucose level may be diminished in patients with NIDDM. In summary, patients with NIDDM possess markedly decreased maximal insulin responsiveness to the potentiating effects of glucose. Such a defect indicates the presence of a reduced B cell secretory capacity and suggests a marked generalized impairment of B cell function in patients with NIDDM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci111542

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Exploratory Data Analysis
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,707
Applied Regression Analysis
Hahn, G. J., Draper, N. R., & Smith, H. C. (1982) · Technometrics · doi:10.2307/1267833 · Cited by 5,820
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Exploratory Data Analysis
Tukey, J. W. (1977) · International Linear Collider · Cited by 2,155
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Effects of arterial versus venous sampling on analysis of glucose kinetics in man
McGuire, E. A., Helderman, J. H., Tobin, J. D., Andres, R., & Berman, M. D. (1976) · Journal of Applied Physiology · doi:10.1152/jappl.1976.41.4.565 · Cited by 704
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 391
Insulin secretion in diabetes mellitus
Pfeifer, M. A., Halter, J. B., & Porte, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90579-9 · Cited by 367
Self-citation
The pancreatic islets in diabetes
Gepts, W., & LeCompte, P. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90417-4 · Cited by 348
Glucagon and the a Cell
Unger, R. H., & Orci, L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106183042504 · Cited by 303

Flagged first, then by citations

Show all 37 references

Sorted by citations

Items 101–200 of 482

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
Larsson, H. E., & Åhrén, B. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.650 · Cited by 98
Immunoreactive Gastric Inhibitory Polypeptide*
Krarup, T. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-122 · Cited by 94
Incretins and the development of type 2 diabetes
Meier, J. J., & Nauck, M. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0034-7 · Cited by 96
Incretin Effects on β-Cell Function, Replication, and Mass
Garber, A. J. (2011) · Diabetes Care · doi:10.2337/dc11-s230 · Cited by 92
Treatment with a Somatostatin Analog Decreases Pancreatic B-Cell and Whole Body Sensitivity to Glucose*
Kahn, S. E., Klaff, L. J., Schwartz, M. W., Beard, J. C., Bergman, R. N., Taborsky, G. J., & Porte, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-994 · Cited by 91
Self-citation
Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses.
Utzschneider, K., Prigeon, R., Carr, D., Hull, R., Tong, J., Shofer, J., Retzlaff, B., Knopp, R., & Kahn, S. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1963 · Cited by 101
THE EFFECTS OF MAINTENANCE DOSES OF FK506 VERSUS CYCLOSPORIN A ON GLUCOSE AND LIPID METABOLISM AFTER ORTHOTOPIC LIVER TRANSPLANTATION1
Fernandez, L. A., Lehmann, R., Luzi, L., Battezzati, A., Angelico, M. C., Ricordi, C., Tzakis, A. G., & Alejandro, R. (1999) · Transplantation · doi:10.1097/00007890-199911270-00017 · Cited by 90
Protection of pancreatic beta-cells: Is it feasible?
Bonora, E. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.05.004 · Cited by 90
Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans.
Seaquist, E. R., Kahn, S. E., CLARK, P. M. S., Hales, C. N., Porte, D., & Robertson, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118435 · Cited by 89
Self-citation
Review of methods for measuring β‐cell function: D esign considerations from the R estoring I nsulin S ecretion ( RISE ) C onsortium
Hannon, T. S., Kahn, S. E., Utzschneider, K. M., Buchanan, T. A., Nadeau, K. J., Zeitler, P. S., Ehrmann, D. A., Arslanian, S. A., Caprio, S., Edelstein, S. L., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13005 · Cited by 92
Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison
Ilag, L. L., Kerr, L., Malone, J. K., & Tan, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.003 · Cited by 84
Insulin and Glucagon Secretion in Patients with Slowly Progressing Autoimmune Diabetes (LADA)
Carlsson, Å., Sundkvist, G., Groop, L., & Tuomi, T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6228 · Cited by 98
Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial
Foley, J. E., Bunck, M. C., Möller-Goede, D. L., Poelma, M., Nijpels, G., Eekhoff, E. M., Schweizer, A., Heine, R. J., & Diamant, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2167-8 · Cited by 83
Serum Dioxin, Insulin, Fasting Glucose, and Sex Hormone-Binding Globulin in Veterans of Operation Ranch Hand
Michalek, J. E., Akhtar, F. Z., & Kiel, J. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5663 · Cited by 82
Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance
Båvenholm, P., Pigon, J., Östenson, C., & Efendić, S. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1449 · Cited by 81
Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension
Levy, J., Zemel, M. B., & Sowers, J. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90489-0 · Cited by 78
Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion
Fritsche, A., Stefan, N., Hardt, E., Häring, H., & Stümvoll, M. (2000) · Diabetologia · doi:10.1007/s001250051461 · Cited by 76
Effect of Experimental Elevation of Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Healthy Carriers of the Pro12Ala Polymorphism of the Peroxisome Proliferator–Activated Receptor-γ2 Gene
Stefan, N., Fritsche, A., Häring, H. U., & Stümvoll, M. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1143 · Cited by 76
Relationship of Islet Function to Insulin Action in Human Obesity*
BEARD, J. C., WARD, W. K., WALLUM, B. J., & PORTE, D. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-59 · Cited by 75
Self-citation
Melatonin stimulates glucagon secretion in vitro and in vivo
Bähr, I., Mühlbauer, E., Schucht, H., & Peschke, E. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00848.x · Cited by 74
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus
Singh‐Franco, D., Robles, G. I., & Gazze, D. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.04.005 · Cited by 75
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in type 2 diabetes
Tripathy, D., Eriksson, K. F., Orho-Melander, M., Fredriksson, J., Ahlqvist, G., & Groop, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1393-8 · Cited by 74
Induction of β-Cell Rest by a Kir6.2/SUR1-Selective KATP-Channel Opener Preserves β-Cell Insulin Stores and Insulin Secretion in Human Islets Cultured at High (11 mM) Glucose
Ritzel, R. A., Hansen, J. B., Veldhuis, J. D., & Butler, P. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031120 · Cited by 74
Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series
Shankar, S. S., Vella, A. V., Raymond, R. H., Staten, M. A., Calle, R. A., Bergman, R. N., Cao, C., Chen, D., Cobelli, C., Man, C. D., et al. (2016) · Diabetes Care · doi:10.2337/dc15-0931 · Cited by 74
Diet-Induced Weight Loss Is Associated with an Improvement in β-Cell Function in Older Men
Utzschneider, K. M., Carr, D. B., Barsness, S. M., Kahn, S. E., & Schwartz, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031827 · Cited by 73
Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity
Larsson, H., & Ahrén, B. (1999) · Diabetologia · doi:10.1007/s001250051251 · Cited by 73
Metabolic and health complications of obesity
(1990) · Disease-a-Month · doi:10.1016/0011-5029(90)90015-j · Cited by 74
Effects of Treatment of Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes With Metformin Alone or in Combination With Insulin Glargine on β-Cell Function: Comparison of Responses In Youth And Adults
(2019) · Diabetes · doi:10.2337/db19-0299 · Cited by 77
Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets
Hatakeyama, H., Kishimoto, T. E., Nemoto, T., Kasai, H., & Takahashi, N. K. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.096560 · Cited by 71
High Passage MIN6 Cells Have Impaired Insulin Secretion with Impaired Glucose and Lipid Oxidation
Cheng, K., Delghingaro‐Augusto, V., Nolan, C. J., Turner, N. A., Hallahan, N., Andrikopoulos, S., & Gunton, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040868 · Cited by 82
Emergence of insulin resistance in juvenile baboon offspring of mothers exposed to moderate maternal nutrient reduction
Choi, J., Li, C., McDonald, T. J., Comuzzie, A. G., Mattern, V. L., & Nathanielsz, P. W. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00051.2011 · Cited by 71
Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
Hosokawa, Y., Hosokawa, H., Chen, C., & Leahy, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118387 · Cited by 71
SNARE Conformational Changes that Prepare Vesicles for Exocytosis
Takahashi, N., Hatakeyama, H., Okado, H., Noguchi, J., Ohno, M., & Kasai, H. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.013 · Cited by 70
Consequences on β-Cell Function and Reserve After Long-Term Pancreas Transplantation
Robertson, R. P. (2004) · Diabetes · doi:10.2337/diabetes.53.3.633 · Cited by 70
Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes
Derosa, G., Franzetti, I. G., Querci, F., Carbone, A., Ciccarelli, L., Piccinni, M. N., Fogari, E., & Maffioli, P. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03699.x · Cited by 70
A Review of Closed-Loop Algorithms for Glycemic Control in the Treatment of Type 1 Diabetes
Youssef, J. E., Castle, J. R., & Ward, W. K. (2009) · Algorithms · doi:10.3390/a2010518 · Cited by 69
Self-citation
The Prohormone VGF Regulates β Cell Function via Insulin Secretory Granule Biogenesis
Stephens, S. B., Edwards, R. J., Sadahiro, M., Lin, W., Jiang, C. S., Salton, S. R., & Newgard, C. B. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.050 · Cited by 66
β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance
Åhrén, B. (2008) · Diabetes · doi:10.2337/db08-1158 · Cited by 71
Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with Type 2 (non-insulin-dependent) diabetes mellitus
Vaag, A. A., Damsbo, P., Nielsen, O. H., & Beck‐Nielsen, H. (1992) · Diabetologia · doi:10.1007/bf00400856 · Cited by 67
Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.
Prigeon, R., Kahn, S. E., & Porte, D. (1998) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.83.3.4641 · Cited by 79
Self-citation
Type 2 diabetes mellitus is becoming the most common type of diabetes in school children
Pontiroli, A. E. (2004) · Acta Diabetologica · doi:10.1007/s00592-004-0149-8 · Cited by 65
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients
Derosa, G., Carbone, A., Franzetti, I., Querci, F., Fogari, E., Bianchi, L., Bonaventura, A., Romano, D., Cicero, A. F. G., & Maffioli, P. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.05.022 · Cited by 68
Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance
Åhrén, B., & Pacini, G. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e701 · Cited by 66
Pancreatic α-cell dysfunction in diabetes
Burcelin, R., Knauf, C., & Cani, P. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73395-0 · Cited by 71
Effects of Weight Loss and Reduced Hyperglycemia on the Kinetics of Insulin Secretion in Obese Non-Insulin Dependent Diabetes Mellitus*
Gumbiner, B., Polonsky, K. S., Beltz, W. F., Griver, K., Wallace, P., Brechtel, G., & Henry, R. R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1594 · Cited by 66
Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women
Larsson, H. E., & Åhrén, B. (2000) · Diabetologia · doi:10.1007/s001250050029 · Cited by 65
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 75
Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal,,
Gannon, M. C., Nuttall, J. A., & Nuttall, F. Q. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1016 · Cited by 62
Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction
Limesand, S. W., & Hay, W. W. (2002) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00095.x · Cited by 62
Glucagon-Like Peptide 1 Increases Secretory Burst Mass of Pulsatile Insulin Secretion in Patients With Type 2 Diabetes and Impaired Glucose Tolerance
Ritzel, R. A., Schulte, M., Pørksen, N. K., Nauck, M., Holst, J. J., Juhl, C. B., März, W., Schmitz, O., Schmiegel, W., & Nauck, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.4.776 · Cited by 62
Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance
Larsson, H. E., & Ahr�n, B. (1996) · Diabetologia · doi:10.1007/bf00400660 · Cited by 60
An examination of β‐cell function measures and their potential use for estimating β‐cell mass
Kahn, S. E., Carr, D. B., Faulenbach, M. V., & Utzschneider, K. M. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00945.x · Cited by 59
Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetes.
Larsen, M. O., Rolin, B., Wilken, M., Carr, R. D., & Gotfredsen, C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.118 · Cited by 69
Chromogranin B regulates early-stage insulin granule trafficking from the Golgi in pancreatic islet β-cells
Bearrows, S. C., Bauchle, C. J., Becker, M., Haldeman, J. M., Swaminathan, S., & Stephens, S. B. (2019) · Journal of Cell Science · doi:10.1242/jcs.231373 · Cited by 55
Effects of training and detraining on dose-response relationship between glucose and insulin secretion
Mikines, K. J., Sonne, B., Tronier, B., & Galbo, H. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.5.e588 · Cited by 59
Islet cell function: α and β cells - partners towards normoglycaemia: α and β cells and normoglycaemia
Göke, B. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01686.x · Cited by 58
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
Chon, S., & Gautier, J. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.99 · Cited by 56
Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans
Mezza, T., Ferraro, P. M., Sun, V. A., Moffa, S., CEFALO, C. M. A., Quero, G., Cinti, F., Sorice, G. P., Pontecorvi, A., Folli, F. B., et al. (2018) · Diabetes · doi:10.2337/db18-0279 · Cited by 57
Loss of Nuclear and Membrane Estrogen Receptor-α Differentially Impairs Insulin Secretion and Action in Male and Female Mice
Allard, C., Morford, J. J., Xu, B., SALWEN, B. D., Xu, W., Desmoulins, L. D., Zsombok, A., Kim, J. K., Levin, E. R., & Mauvais‐Jarvis, F. (2018) · Diabetes · doi:10.2337/db18-0293 · Cited by 56
Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus
Olefsky, J. M. (1985) · The American Journal of Medicine · doi:10.1016/s0002-9343(85)80001-2 · Cited by 57
Glucose Stimulates Pulsatile Insulin Secretion from Human Pancreatic Islets by Increasing Secretory Burst Mass: Dose-Response Relationships
Ritzel, R. A., Veldhuis, J. D., & Butler, P. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021250 · Cited by 56
Chapter 4: Pre‐clinical efficacy and complication data required to justify a clinical trial
Cooper, D. K. C., & Casu, A. (2009) · Xenotransplantation · doi:10.1111/j.1399-3089.2009.00543.x · Cited by 55
Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors
Watanabe, R. M., Azen, C., Roy, S., Perlman, J. A., & Bergman, R. N. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962320 · Cited by 55
Glucosamine infusion in rats mimics the β-cell dysfunction of non—insulin-dependent diabetes mellitus
Shankar, R. R., Zhu, J. S., & Baron, A. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90242-6 · Cited by 55
The elusive cephalic phase insulin response: triggers, mechanisms, and functions
Langhans, W., Watts, A. G., & Spector, A. C. (2022) · Physiological Reviews · doi:10.1152/physrev.00025.2022 · Cited by 57
Studies of diabetic twins
Lo, S. S. S., Tun, R. Y. M., Hawa, M. I., & Leslie, R. D. G. (1991) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610070403 · Cited by 54
A novel acylated form of (d-Ala2)GIP with improved antidiabetic potential, lacking effect on body fat stores
Martin, C. M. A., Irwin, N., Flatt, P. R., & Gault, V. A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.011 · Cited by 53
Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?
Irwin, N., Gault, V. A., & Flatt, P. R. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.513381 · Cited by 55
High‐Fat High‐Energy Feeding Impairs Fasting Glucose and Increases Fasting Insulin Levels in the Göttingen Minipig
Larsen, M. O., Rolin, B., Wilken, M., Carr, R. D., & Svendsen, Ø. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04297.x · Cited by 57
Exercise Training in Obese Diabetic Patients
Zierath, J. R., & Wallberg‐Henriksson, H. (1992) · Sports Medicine · doi:10.2165/00007256-199214030-00004 · Cited by 51
Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and management
Pontiroli, A. E., Caiderara, A., & Pozza, G. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100104 · Cited by 53
Examining the Effects of Hyperglycemia on Pancreatic Endocrine Function in Humans: Evidence forin VivoGlucotoxicity
Solomon, T. P. J., Knudsen, S. H., Karstoft, K., Winding, K. M., Holst, J. J., & Pedersen, B. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2097 · Cited by 54
Clinical aspects of islet B‐cell function in non‐insulin‐dependent diabetes mellitus
Ward, W. K., Beard, J. C., & Porte, D. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610020305 · Cited by 51
Self-citation
Mathematical model of blood glucose dynamics by emulating the pathophysiology of glucose metabolism in type 2 diabetes mellitus
López-Palau, N. E., & Olais-Govea, J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69629-0 · Cited by 53
A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility
Fritsche, Stefan, N., Hardt, Schützenauer, Häring, & Stümvoll, M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00649.x · Cited by 50
Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure
Yki-Järvinen, H., Esko, N., Helve, E., & Taskinen, M. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90412-3 · Cited by 50
Insulin secretory capacity in endurance-trained and untrained young men
King, D. S., Staten, M. A., Kohrt, W. M., Dalsky, G. P., Elahi, D., & Holloszy, J. O. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.2.e155 · Cited by 49
The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse islets
Hermans, M. P., Schmeer, W., & Henquin, J. C. (1987) · Diabetologia · doi:10.1007/bf00277325 · Cited by 49
Long-Term Metabolic and Hormonal Effects of Exenatide on Islet Transplant Recipients with Allograft Dysfunction
Faradji, R. N., Froud, T., Messinger, S., Monroy, K., Pileggi, A., Mineo, D., Tharavanij, T., Mendez, A. J., Ricordi, C., & Alejandro, R. (2009) · Cell Transplantation · doi:10.3727/096368909x474456 · Cited by 48
Glucose-induced insulin secretion in isolated human islets: Does it truly reflect β-cell function in vivo?
Henquin, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101212 · Cited by 48
Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
Røder, M., Schwartz, R. S., Prigeon, R., & Kahn, S. E. (2000) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.85.6.6635 · Cited by 61
Glucagon and the Glucagon-like Peptides
Drucker, D. J. (1990) · Pancreas · doi:10.1097/00006676-199007000-00018 · Cited by 48
Pancreatic β-Cell Rest Replenishes Insulin Secretory Capacity and Attenuates Diabetes in an Extreme Model of Obese Type 2 Diabetes
Boland, B. B., Brown, C. L., Boland, M. L., Cann, J. A., Sulikowski, M., Hansen, G., Grønlund, R. V., King, W., Rondinone, C. M., Trevaskis, J. L., et al. (2018) · Diabetes · doi:10.2337/db18-0304 · Cited by 48
Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes
Bock, G., Man, C. D., Campioni, M., Chittilapilly, E. G., Basu, R., TOFFOLO, G. M., Cobelli, C., & Rizza, R. A. (2007) · Diabetes · doi:10.2337/db06-1272 · Cited by 50
Vildagliptin Added to Metformin on β-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients
Derosa, G., Ragonesi, P. D., Carbone, A., Fogari, E., Bianchi, L., Bonaventura, A., Romano, D., Cicero, A. F. G., & Maffioli, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0278 · Cited by 50
Type 2 Diabetes Mellitus
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 53
Effects of free fatty acids on insulin secretion in obesity
Zraika, S., Dunlop, M., Proietto, J., & Andrikopoulos, S. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00062.x · Cited by 47
Islet dysfunction in non-insulin-dependent diabetes mellitus
Kahn, S. E., & Porte, D. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90392-0 · Cited by 49
Self-citation
Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study
Sam, S., Edelstein, S. L., Arslanian, S. A., Barengolts, E., Buchanan, T. A., Caprio, S., Ehrmann, D. A., Hannon, T. S., Tjaden, A. H., Kahn, S. E., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0027 · Cited by 49
Impaired incretin secretion and pancreatic dysfunction with older age and diabetes
Geloneze, B., de Oliveira, M. D. S., Vasques, A. C. J., Novaes, F. S., Pareja, J. C., & Tambascia, M. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.004 · Cited by 49
Disruption of Growth Factor Receptor–Binding Protein 10 in the Pancreas Enhances β-Cell Proliferation and Protects Mice From Streptozotocin-Induced β-Cell Apoptosis
Zhang, J., Zhang, N., Liu, M., Li, X., Zhou, L., Huang, W., Xu, Z., Liu, J., Musi, N., DeFronzo, R. A., et al. (2012) · Diabetes · doi:10.2337/db12-0249 · Cited by 46
Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats
Jamison, R. A., Stark, R., Dong, J., Yonemitsu, S., Zhang, D., Shulman, G. I., & Kibbey, R. G. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00175.2011 · Cited by 46
AN INTEGRATED VIEW OF β-CELL DYSFUNCTION IN TYPE-II DIABETES
Poitout, D., & Robertson, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.69 · Cited by 62
Overview of the Gliptin Class (Dipeptidyl Peptidase-4 Inhibitors) in Clinical Practice
Bohannon, N. J. V. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.01.1953 · Cited by 45
Quantification of Insulin Secretion in Relation to Insulin Sensitivity in Nondiabetic Postmenopausal Women
Åhrén, B., & Larsson, H. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s202 · Cited by 45
NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat
Carr, R. D., Brand, C. L., Bödvarsdóttir, T., Hansen, J. B., & Sturis, J. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2513 · Cited by 45
Postprandial Effects of SMS 201-995 on Gut Hormones and Glucose Tolerance
Williams, G. H., Fuessl, H., KRAENZLIN, M. E., & Bloom, S. R. (1986) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528609087434 · Cited by 45
Islet dysfunction in obese women with impaired glucose tolerance
Larsson, H., & Ahrén, B. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90227-9 · Cited by 44
Loci for insulin processing and secretion provide insight into type 2 diabetes risk
Broadaway, K. A., Yin, X., Williamson, A., Parsons, V. A., Wilson, E. P., Moxley, A. H., Vadlamudi, S., Varshney, A., Jackson, A., Ahuja, V., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.01.002 · Cited by 47
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes
Pistrosch, F., Köhler, C. U., Schäper, F., Landgraf, W., Forst, T. M., & Hanefeld, M. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0451-9 · Cited by 48

Authors: Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D.
Affiliations: University of Washington (US)
United States Department of Veterans Affairs (US)
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1984-10-01
Volume: 74
Issue: 4
Pages: 1318-1328
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci111542
PMC: PMC425299
OpenAlex: W1969480413
Cited by: 483
References: 37
Citations by year: 2026: 1 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 12 · 2020: 13 · 2019: 10 · 2018: 13 · 2017: 8 · 2016: 19 · 2015: 10 · 2014: 19 · 2013: 14 · 2012: 14
FWCI: 10.29
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p30am017047-11, 5r01am012829-17)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: type 2 diabetes, insulin secretion, acute insulin response, arginine stimulation, glucagon response, glucose-stimulated insulin secretion, hyperglycemia, Michaelis-Menten kinetics
MeSH terms: Insulin Secretion, Adult, Aging, Arginine, Blood Glucose, Catecholamines, Diabetes Mellitus, Diabetes Mellitus, Type 2, Glucagon, Humans, Insulin, Islets of Langerhans, Male, Middle Aged, Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks